Detalhe da pesquisa
1.
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.
Br J Haematol
; 2024 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38735683
2.
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.
Histopathology
; 2024 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38686611
3.
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.
Haematologica
; 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38572560
4.
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Eur Heart J
; 44(22): 2029-2042, 2023 Jun 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36939851
5.
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Blood
; 138(7): 531-543, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33851211
6.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Blood
; 138(26): 2828-2837, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34653242
7.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36251406
8.
Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience.
Acta Haematol
; 2023 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37989105
9.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32688395
10.
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Haematologica
; 106(8): 2086-2094, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33054114
11.
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
J Natl Compr Canc Netw
; : 1-4, 2020 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32871558
12.
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
Haematologica
; 104(7): 1378-1387, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30523054
13.
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy.
Mol Ther
; 26(8): 1896-1905, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29910179
14.
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.
Blood
; 127(26): 3312-20, 2016 06 30.
Artigo
Inglês
| MEDLINE | ID: mdl-27207800
15.
Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells.
Cytotherapy
; 18(11): 1393-1409, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27592405
16.
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.
J Pediatr
; 167(3): 765-9.e1, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26148662
17.
A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation.
Biol Blood Marrow Transplant
; 20(8): 1229-37, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24769329
18.
Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis.
Blood
; 129(13): 1878-1881, 2017 03 30.
Artigo
Inglês
| MEDLINE | ID: mdl-28122741
19.
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
Pediatr Blood Cancer
; 61(7): 1289-94, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24623601
20.
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
Br J Haematol
; 162(5): 678-83, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23802659